Category(s):
Therapeutic
Patent Information:
For Information, Contact:
Chris Baker
Senior Business Manager
UCL Business PLC
c.baker@uclb.com
Keywords:

Formulations for the Prevention of Neural Tube Defects

Case ID:
89-111
Web Published:
26/11/2012
Description:

Available for: License

 

<h2>Summary</h2>

Exploring ways to prevent birth defects, researchers at the UCL Institute of Child Health have discovered novel supplements that if taken in pregnancy can reduce the chance of the baby having neural tube defects such as spina bifida or anencephaly. These are important in pregnancies where folic acid and other supplements are not as effective. A new patent has been filed we are supporting work to validate and test combinations in animal models.

 

<h2>Market Opportunity</h2> 

Maternal folic acid supplementation during early pregnancy reduces the risk of neural tube defects. However studies have shown that around 30-50% of neural tube defects are not preventable by folic acid and additional therapies are needed.

 

<h2>Further Information</h2> 

Please contact Chris Baker, Senior Business Manager |T: +44 (0)20 7679 9000 |E: c.baker@uclb.com

 

The technology referred to herein is experimental in nature and UCL Business PLC makes no representations and gives no warranties of any kind, either express or implied, in relation to the technology and, in particular but without limiting the foregoing, UCL Business PLC gives no express or implied warranties of merchantability, satisfactory quality or fitness for a particular purpose.

© 2017. All Rights Reserved. Powered by Inteum